Reuters logo
BRIEF-Bausch + lomb receives 510(k) clearance from FDA for stellaris elite next-generation phacoemulsification platform
April 6, 2017 / 12:05 PM / 8 months ago

BRIEF-Bausch + lomb receives 510(k) clearance from FDA for stellaris elite next-generation phacoemulsification platform

April 6 (Reuters) - Valeant Pharmaceuticals International Inc:

* Bausch + lomb receives 510(k) clearance from fda for stellaris elite™ next-generation phacoemulsification platform

* Bausch + lomb receives 510(k) clearance from fda for stellaris elite™ next-generation phacoemulsification platform

* Valeant - bausch + lomb plans to launch retina applications for stellaris elite this summer

* Valeant - retina applications for stellaris elite will integrate both retina and cataract capabilities into a single machine Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below